INSIGHTS ON CLINICAL TRIAL PARTNERING

• Elevating Patient Centricity In Clinical Trials

  How can the integration of patient perspectives throughout the clinical trial process enhance engagement and outcomes?

• Mergers And Acquisitions: How Institutional Knowledge Protecting Value

  M&A transitions can either preserve momentum or create costly setbacks. Learn how protecting institutional knowledge helps sponsors reduce risk, maintain continuity, and accelerate development.

• The Role Of Company Culture In FSP Partnerships

  This piece explores intentional culture-building as a strategic asset in FSP engagements, transforming transactional relationships into enduring, high-performing partnerships.

• Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call

  Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

• We Made Five Predictions For Clinical Research Last Year. Here's What Happened

  1/22/2026

  Review 2025’s gap between AI discovery and trial execution, highlighting legislative and FDA shifts to help sponsors operationalize participant experience for 2026.

• Rare Diseases And The Integrated CDMO Support System

  4/7/2026

  Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.

• Redefining eSource: A Smarter, Site-Centric Approach To Clinical Trial Data Capture

  3/26/2026

  Discover how AI-powered extraction and site-centric workflows improve data quality and reduce administrative burdens for research teams.

• What Sponsors Must Know To Safeguard Ocular Endpoints

  7/7/2025

  Explore the necessity of incorporating imaging methodologies early in the trial design to improve data quality and overall trial efficiency.

• Rethinking Trial Access Through Trust-Driven Design And Local Collaboration

  5/19/2026

  Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.